Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Seunggu J. Han; Gerald Reis; Gary Kohanbash; Shruti Shrivastav; Stephen T. Magill; Annette M. Molinaro; Michael W. McDermott; Philip V. Theodosopoulos; Manish K. Aghi; Mitchel S. Berger; Nicholas A. Butowski; Igor Barani; Joanna J. Phillips; Arie Perry; Hideho Okada

doi:10.1007/S11060-016-2256-0

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Seunggu J. Han, Gerald Reis, Gary Kohanbash, Shruti Shrivastav, Stephen T. Magill, Annette M. Molinaro, Michael W. McDermott, Philip V. Theodosopoulos, Manish K. Aghi, Mitchel S. Berger, Nicholas A. Butowski, Igor Barani, Joanna J. Phillips, Arie Perry, Hideho Okada

Miami Neuroscience Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	130
DOIs	https://doi.org/10.1007/S11060-016-2256-0
State	Published - Sep 13 2016

Disciplines

Biology
Oncology
Pathology

Access to Document

10.1007/S11060-016-2256-0License: Unspecified

Cite this

Han, S. J., Reis, G., Kohanbash, G., Shrivastav, S., Magill, S. T., Molinaro, A. M., McDermott, M. W., Theodosopoulos, P. V., Aghi, M. K., Berger, M. S., Butowski, N. A., Barani, I., Phillips, J. J., Perry, A., & Okada, H. (2016). Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma. Journal of neuro-oncology, 130. https://doi.org/10.1007/S11060-016-2256-0

@article{dc825ce60c2145bd9d0aadf15c7ac762,

title = "Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.",

author = "Han, {Seunggu J.} and Gerald Reis and Gary Kohanbash and Shruti Shrivastav and Magill, {Stephen T.} and Molinaro, {Annette M.} and McDermott, {Michael W.} and Theodosopoulos, {Philip V.} and Aghi, {Manish K.} and Berger, {Mitchel S.} and Butowski, {Nicholas A.} and Igor Barani and Phillips, {Joanna J.} and Arie Perry and Hideho Okada",

note = "While immunotherapy may offer promising new approaches for high grade meningiomas, little is currently known of the immune landscape in meningiomas. We sought to characterize the immune microenvironment and a potentially targetable antigen mesothelin across WHO grade I-III cases of meningiomas, and how infiltrating immune populations relate to patient outcomes.",

year = "2016",

month = sep,

day = "13",

doi = "10.1007/S11060-016-2256-0",

language = "American English",

volume = "130",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

AU - Han, Seunggu J.

AU - Reis, Gerald

AU - Kohanbash, Gary

AU - Shrivastav, Shruti

AU - Magill, Stephen T.

AU - Molinaro, Annette M.

AU - McDermott, Michael W.

AU - Theodosopoulos, Philip V.

AU - Aghi, Manish K.

AU - Berger, Mitchel S.

AU - Butowski, Nicholas A.

AU - Barani, Igor

AU - Phillips, Joanna J.

AU - Perry, Arie

AU - Okada, Hideho

N1 - While immunotherapy may offer promising new approaches for high grade meningiomas, little is currently known of the immune landscape in meningiomas. We sought to characterize the immune microenvironment and a potentially targetable antigen mesothelin across WHO grade I-III cases of meningiomas, and how infiltrating immune populations relate to patient outcomes.

PY - 2016/9/13

Y1 - 2016/9/13

UR - https://link.springer.com/article/10.1007/s11060-016-2256-0

U2 - 10.1007/S11060-016-2256-0

DO - 10.1007/S11060-016-2256-0

M3 - Article

VL - 130

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Disciplines

Access to Document

Other files and links

Cite this